- Home
- SSY vs CHEK Comparison
SSY vs CHEK Comparison
Compare SSY & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- CHEK
- Stock Information
- Founded
- SSY 1959
- CHEK 2004
- Country
- SSY United States
- CHEK Israel
- Employees
- SSY N/A
- CHEK N/A
- Industry
- SSY Hospital/Nursing Management
- CHEK Medical Electronics
- Sector
- SSY Health Care
- CHEK Health Care
- Exchange
- SSY Nasdaq
- CHEK Nasdaq
- Market Cap
- SSY 5.3M
- CHEK 5.1M
- IPO Year
- SSY N/A
- CHEK 2015
- Fundamental
- Price
- SSY $0.75
- CHEK $0.61
- Analyst Decision
- SSY
- CHEK
- Analyst Count
- SSY 0
- CHEK 0
- Target Price
- SSY N/A
- CHEK N/A
- AVG Volume (30 Days)
- SSY 17.6K
- CHEK 14.0K
- Earning Date
- SSY 02-11-2025
- CHEK 02-14-2025
- Dividend Yield
- SSY N/A
- CHEK N/A
- EPS Growth
- SSY N/A
- CHEK N/A
- EPS
- SSY N/A
- CHEK N/A
- Revenue
- SSY $31,808,000.00
- CHEK N/A
- Revenue This Year
- SSY N/A
- CHEK N/A
- Revenue Next Year
- SSY N/A
- CHEK N/A
- P/E Ratio
- SSY N/A
- CHEK N/A
- Revenue Growth
- SSY N/A
- CHEK N/A
- 52 Week Low
- SSY $0.53
- CHEK $0.61
- 52 Week High
- SSY $0.98
- CHEK $3.45
- Technical
- Relative Strength Index (RSI)
- SSY 43.72
- CHEK 19.96
- Support Level
- SSY $0.74
- CHEK $0.61
- Resistance Level
- SSY $0.88
- CHEK $0.83
- Average True Range (ATR)
- SSY 0.04
- CHEK 0.04
- MACD
- SSY -0.00
- CHEK -0.00
- Stochastic Oscillator
- SSY 7.21
- CHEK 0.44
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.